86 related articles for article (PubMed ID: 18452459)
1. Prediction of bone metastases by combination of tartrate-resistant acid phosphatase, alkaline phosphatase and prostate specific antigen in patients with prostate cancer.
Ozu C; Nakashima J; Horiguchi Y; Oya M; Ohigashi T; Murai M
Int J Urol; 2008 May; 15(5):419-22. PubMed ID: 18452459
[TBL] [Abstract][Full Text] [Related]
2. A CXCR4 inhibitor (balixafortide) enhances docetaxel-mediated antitumor activity in a murine model of prostate cancer bone metastasis.
Robinson T; Escara-Wilke J; Dai J; Zimmermann J; Keller ET
Prostate; 2023 Sep; 83(13):1247-1254. PubMed ID: 37244751
[TBL] [Abstract][Full Text] [Related]
3. The clinical association between coagulation indexes, platelet-related parameters, and bone metastasis of newly diagnosed prostate cancer.
Yu Z; Yuan M; Chen G
Eur J Med Res; 2023 Dec; 28(1):587. PubMed ID: 38093347
[TBL] [Abstract][Full Text] [Related]
4. A narrowing range of bone scan in newly diagnosed prostate cancer patients: A retrospective comparative study.
Özgür BC; Gültekin S; Ekici M; Yılmazer D; Alper M
Urol Ann; 2015; 7(2):193-8. PubMed ID: 25835063
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of SPECT/CT bone imaging combined with two serum examinations in patients with bone metastases from pulmonary cancer.
Zhou Y; Li C; Jiang S; Niu F; Cui F; Zhao Y; Wei D; Ma H; Li Y
Clin Transl Oncol; 2024 Jan; 26(1):147-154. PubMed ID: 37269491
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of serum tartrate‑resistant acid phosphatase‑5b for bone metastasis in patients with resectable breast cancer.
Shimoda M; Sato Y; Abe K; Masunaga N; Tsukabe M; Yoshinami T; Sota Y; Miyake T; Tanei T; Shimazu K
Oncol Lett; 2024 Jun; 27(6):250. PubMed ID: 38638841
[TBL] [Abstract][Full Text] [Related]
7. The significance of erythrocyte sedimentation rate as a prognostic factor for patients with prostate cancer: Gunma Urological Oncology Study Group investigation.
Imai K; Suzuki T; Kobayashi M; Yamanaka H; Tomaru Y; Sato J
Jpn J Cancer Res; 1990 Oct; 81(10):971-4. PubMed ID: 2121683
[TBL] [Abstract][Full Text] [Related]
8. The association between serum albumin and alkaline phosphatase in cancer patients.
Jiang Y; Cai Y; Ding Y; Kong X; Li Z
Medicine (Baltimore); 2024 Mar; 103(13):e37526. PubMed ID: 38552093
[TBL] [Abstract][Full Text] [Related]
9. Distinguishable Colorimetric Biosensor for Diagnosis of Prostate Cancer Bone Metastases.
Li M; Ding C; Zhang D; Chen W; Yan Z; Chen Z; Guo Z; Guo L; Huang Y
Adv Sci (Weinh); 2023 Nov; 10(32):e2303159. PubMed ID: 37840414
[TBL] [Abstract][Full Text] [Related]
10. Measurements of peri-prostatic adipose tissue by MRI predict bone metastasis in patients with newly diagnosed prostate cancer.
Liu BH; Mao YH; Li XY; Luo RX; Zhu WA; Su HB; Zeng HD; Chen CH; Zhao X; Zou C; Luo Y
Front Oncol; 2024; 14():1393650. PubMed ID: 38737904
[TBL] [Abstract][Full Text] [Related]
11. Can Bone-Specific Alkaline Phosphatase be a Marker of Vascular Calcification in Type 2 Diabetes Mellitus?
Raizada N; Aslam M; Mishra BK; Chawla D; Madhu SV
Indian J Endocrinol Metab; 2023; 27(2):127-132. PubMed ID: 37292071
[TBL] [Abstract][Full Text] [Related]
12. Do alkaline phosphatases have great potential in the diagnosis, prognosis, and treatment of tumors?
Jiang T; Zeng Q; He J
Transl Cancer Res; 2023 Oct; 12(10):2932-2945. PubMed ID: 37969388
[TBL] [Abstract][Full Text] [Related]
13. Can clinical factors be determinants of bone metastases in non-small cell lung cancer?
Ursavas A; Karadag M; Uzaslan E; Rodoplu E; Demirdögen E; Burgazlioglu B; Gozu RO
Ann Thorac Med; 2007 Jan; 2(1):9-13. PubMed ID: 19724668
[TBL] [Abstract][Full Text] [Related]
14. Four score and 7 years ago: The discovery of acid phosphatase and the birth of prostate cancer biomarkers.
Loughlin KR
Urol Oncol; 2024 Feb; 42(2):25-26. PubMed ID: 38185604
[No Abstract] [Full Text] [Related]
15. Prostatic cancer with bone metastases: serum alkaline phosphatase (SAP) as a predictor of response and the significance of the SAP "flare".
Mackintosh J; Simes J; Raghavan D; Pearson B
Br J Urol; 1990 Jul; 66(1):88-93. PubMed ID: 2203503
[TBL] [Abstract][Full Text] [Related]
16. Implications of serum bone turnover markers in prostate cancer patients with bone metastasis.
Kamiya N; Suzuki H; Yano M; Endo T; Takano M; Komaru A; Kawamura K; Sekita N; Imamoto T; Ichikawa T
Urology; 2010 Jun; 75(6):1446-51. PubMed ID: 20206975
[TBL] [Abstract][Full Text] [Related]
17. Prostatic acid phosphatase is expressed in human prostate cancer bone metastases and promotes osteoblast differentiation.
Kirschenbaum A; Liu XH; Yao S; Leiter A; Levine AC
Ann N Y Acad Sci; 2011 Nov; 1237():64-70. PubMed ID: 22082367
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of bone alkaline phosphatase and prostate specific antigen in the diagnosis of bone metastasis in prostate cancer.
Lorente JA; Morote J; Raventos C; Encabo G; Valenzuela H
J Urol; 1996 Apr; 155(4):1348-51. PubMed ID: 8632571
[TBL] [Abstract][Full Text] [Related]
19. Bone scintigraphy as a new imaging biomarker: the relationship between bone scan index and bone metabolic markers in prostate cancer patients with bone metastases.
Wakabayashi H; Nakajima K; Mizokami A; Namiki M; Inaki A; Taki J; Kinuya S
Ann Nucl Med; 2013 Nov; 27(9):802-7. PubMed ID: 23828554
[TBL] [Abstract][Full Text] [Related]
20. Pattern of enzyme activity following acute myocardial infarction with special reference to gamma-glutamyl transpeptidase.
Säwe U; Erhardt LR; Sjögren A
Acta Med Scand; 1976; 199(3):217-21. PubMed ID: 3949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
